Page 24 - Eng Eong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SINGAPORE - There are some groups of people who should wait to receive a Covid-19 vaccine, including those with a history of severe allergic reactions, said a panel of experts on Thursday (Dec 17). Serious allergies usually refer to people who, in response to a specific stimulus such as a bee sting or medication, experience swelling around the mouth, eyes or face, have difficulty breathing or experience a serious drop in blood pressure, said Associate Professor Lim Poh Lian, the director of the high-level isolation unit at the National Centre for Infectious Diseases. Others who belong to cert...

0 Engagements A Covid-19 vaccination is not risk-free but the risk is small and a person in fact puts himself, his loved ones and society at higher risk by not getting a jab, experts said at a Straits Times Reset webinar series on the A-Z Of Covid-19 vaccines yesterday. "It's not a matter of saying, if I do nothing, we're okay. The weighing is really not between the vaccine and nothing, but the vaccine and the disease," said Associate Professor Lim Poh Lian, the director of the high-level isolation unit at the National Centre for Infectious Diseases and a member of the Ministry of Health's Co...

VIETNAM NEWS HEADLINES DECEMBER 14 Chia sẻ | FaceBookTwitter Email Copy Link Copy link bài viết thành công  14/12/2020    10:35 GMT+7 Third Vietnam Young Talent Congress opens At the event The third Vietnam Young Talent Congress opened in Hanoi on December 13, with the attendance of 400 delegates. Speaking at the opening ceremony, First Secretary of the Ho Chi Minh Communist Youth Union (HCYU) Central Committee Nguyen Anh Tuan said over the past five years, over 1.1 million outst...

Share: Phase 1 Clinical Trials Demonstrate Safety of this Novel Monoclonal Antibody In June 2020, Tychan began its Phase 1 clinical safety trials in humans to evaluate TY027, a monoclonal antibody (mAb) that specifically targets SARS-CoV-2, the virus that causes COVID-19. In October 2020, approval from Health Sciences Authority of Singapore (HSA) was obtained for the Phase 3 clinical trial to begin as part of the progression of the antibody development. The trial will start in Singapore at partner hospitals Singapore General Hospital and National University Hospital, with Changi General Hospi...

Potential COVID-19 antibody drug made by Singapore firm to be tested on 1,305 local, overseas patients Toggle share menu Advertisement Potential COVID-19 antibody drug made by Singapore firm to be tested on 1,305 local, overseas patients Advertisement Singapore Potential COVID-19 antibody drug made by Singapore firm to be tested on 1,305 local, overseas patients Prof Ooi Eng Eong is also a co-founder of biotechnology company Tychan, which developed the world’s first Zika antibody in nine months. (Photo: Tychan) 11 Dec 2020 12:10PM) Share t...